Follow
Mohammad Althubiti, MSc, PhD.
Mohammad Althubiti, MSc, PhD.
Umm Al-Qura University, Mecca, College of Medicine
Verified email at uqu.edu.sa
Title
Cited by
Cited by
Year
Characterization of novel markers of senescence and their prognostic potential in cancer
M Althubiti, L Lezina, S Carrera, R Jukes-Jones, SM Giblett, A Antonov, ...
Cell death & disease 5 (11), e1528-e1528, 2014
2502014
Trends in the incidence and mortality of cancer in Saudi Arabia
MA Althubiti, MMN Eldein
Saudi medical journal 39 (12), 1259, 2018
1242018
Cancer nanomedicine: a new era of successful targeted therapy
MZ El-Readi, MA Althubiti
Journal of Nanomaterials 2019, 1-13, 2019
772019
Detecting and targeting senescent cells using molecularly imprinted nanoparticles
AE Ekpenyong-Akiba, F Canfarotta, B Abd H, M Poblocka, M Casulleras, ...
Nanoscale Horizons 4 (3), 757-768, 2019
732019
BTK modulates p53 activity to enhance apoptotic and senescent responses
M Althubiti, M Rada, J Samuel, JM Escorsa, H Najeeb, KG Lee, KP Lam, ...
Cancer research 76 (18), 5405-5414, 2016
612016
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker
M Poblocka, AL Bassey, VM Smith, M Falcicchio, AS Manso, M Althubiti, ...
Scientific reports 11 (1), 20358, 2021
562021
The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic …
SY Eid, MA Althubiti, ME Abdallah, M Wink, MZ El-Readi
Phytomedicine 77, 153280, 2020
492020
The role of the HIF-1α transcription factor in increased cell division at physiological oxygen tensions
S Carrera, J Senra, MI Acosta, M Althubiti, EM Hammond, PJ De Verdier, ...
PloS one 9 (5), e97938, 2014
402014
8-hydroxy-2’-deoxyguanosine as a discriminatory biomarker for early detection of breast cancer
EEMN Eldin, MZ El-Readi, MMN Eldein, AA Alfalki, MA Althubiti, ...
Clinical breast cancer 19 (2), e385-e393, 2019
352019
Multiple molecular mechanisms to overcome multidrug resistance in cancer by natural secondary metabolites
MZ El-Readi, AM Al-Abd, MA Althubiti, RA Almaimani, HS Al-Amoodi, ...
Frontiers in pharmacology 12, 658513, 2021
302021
BTK blocks the inhibitory effects of MDM2 on p53 activity
M Rada, M Althubiti, AE Ekpenyong-Akiba, KG Lee, KP Lam, O Fedorova, ...
Oncotarget 8 (63), 106639, 2017
272017
Tamoxifen and the PI3K inhibitor: LY294002 synergistically induce apoptosis and cell cycle arrest in breast cancer MCF-7 cells
ME Abdallah, MZ El-Readi, MA Althubiti, RA Almaimani, AM Ismail, S Idris, ...
Molecules 25 (15), 3355, 2020
252020
Mutation frequencies in endometrial cancer patients of different ethnicities and tumor grades: An analytical study
MA Althubiti
Saudi Journal of Medicine & Medical Sciences 7 (1), 16-21, 2019
252019
Amelioration of age‐related brain function decline by Bruton's tyrosine kinase inhibition
AE Ekpenyong‐Akiba, M Poblocka, M Althubiti, M Rada, D Jurk, ...
Aging Cell 19 (1), e13079, 2020
192020
Beta 2 microglobulin correlates with oxidative stress in elderly
M Althubiti, M Elzubier, GS Alotaibi, MA Althubaiti, HH Alsadi, ZA Alhazmi, ...
Experimental Gerontology 150, 111359, 2021
162021
In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K …
RA Almaimani, A Aslam, J Ahmad, MZ El-Readi, ME El-Boshy, ...
Cancers 14 (6), 1538, 2022
142022
Overexpression of inducible nitric oxide synthase in allergic and nonallergic nasal polyp
AA Sadek, S Abdelwahab, SY Eid, RA Almaimani, MA Althubiti, ...
Oxidative medicine and cellular longevity 2019, 2019
122019
Detection of senescent cells by extracellular markers using a flow cytometry-based approach
M Althubiti, S Macip
Oncogene-Induced Senescence: Methods and Protocols, 147-153, 2017
122017
Evaluation of the diagnostic and predicative values of 8-iso-prostaglandin F2α as a biomarker of breast cancer
EEM Nour Eldin, MM Nour Eldein, MZ El-Readi, AA Mirza, SH Fatani, ...
Oncology research and treatment 43 (10), 506-517, 2020
112020
Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis. 2014; 5: e1528
M Althubiti, L Lezina, S Carrera, R Jukes-Jones, SM Giblett, A Antonov, ...
9
The system can't perform the operation now. Try again later.
Articles 1–20